Evaluating human cancer cell metastasis in zebrafish

Area of Science:

• Oncology
• Zebrafish models
• Cancer metastasis research

Background:

• Traditional in vivo metastasis assays in mice are inefficient and costly.
• Zebrafish larvae lack a developed adaptive immune system, allowing survival of transplanted human cancer cells.
• Previous reports on zebrafish metastasis models are isolated, lacking systematic evaluation.

Purpose of the Study:

• To systematically evaluate the robustness of the zebrafish model for assessing human cancer cell metastasis.
• To determine if zebrafish can accurately report the metastatic potential of various human cancer cell lines.
• To establish zebrafish as a viable, cost-effective alternative for metastasis research.

Main Methods:

• Human cancer cell lines were stained and injected into the perivitelline space of 2-day-old zebrafish larvae.
• Metastasis was assessed after 2-4 days using confocal microscopy and quantified with Fiji software.
• Cancer cell lines with known metastatic potential, including breast, prostate, colon, and pancreas cancers, were utilized.

Main Results:

• Metastasis in zebrafish was proportional to in vitro invasion potential across multiple cancer types.
• Highly metastatic cell lines (MDA231, DU145, SW620, ASPC-1) showed widespread dissemination within 24-48 hours.
• Non-invasive cell lines (T47D, LNCaP, HT29) did not metastasize in zebrafish, validating the model's accuracy.
• Genetic manipulations (JAK1/2 inactivation, WASF3 knockdown) affecting invasion in vitro were mirrored by suppressed metastasis in zebrafish.
• The model successfully evaluated metastatic ability of cancer cells from primary lung tumors.

Conclusions:

• The zebrafish model provides a rapid, robust, and inexpensive method for evaluating human cancer cell metastatic potential.
• This model allows for critical assessment of how genetic manipulations impact metastasis.
• The zebrafish system can be used to determine if primary tumors contain metastatic cells.